| 6-OHDA | 6-hydroxydopamine |
| AD | Alzheimer’s diseases |
| ARE | Antioxidant response element |
| BBB | Blood–brain barrier |
| DA | Dopaminergic |
| DAMPs | Damage-associated molecular patterns |
| EAE | Experimental autoimmune encephalomyelitis |
| GPx: | Glutathione peroxidase |
| LPS | lipopolysaccharide |
| MPTP | 1-methyl-4-phenyl-1: 2, 3, 6-tetrahydropyridine; |
| MS | Multiple sclerosis |
| NF-κB | Nuclear factor kappa light chain-enhancer of activated B cells |
| Nrf2 | Nuclear factor erythroid |
| PAMPs | Pathogen-associated molecular patterns |
| PD | Parkinson’s disease |
| PRRs | Pattern recognition receptors |
| PTZ | Pentylenetetrazol |
| ROS | Reactive oxygen species |
| SOD | Superoxide dismutase |
| TBI | Traumatic brain injury |
| TH | Tyrosine hydroxylase |
| TLR | Toll-like receptors |